|
YRDC expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.30300000000805E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.14460000003136E-06 |
| Normal-vs-Stage2 |
3.876300E-03 |
| Normal-vs-Stage3 |
9.664500E-03 |
| Normal-vs-Stage4 |
4.127600E-02 |
| Stage1-vs-Stage2 |
7.974400E-01 |
| Stage1-vs-Stage3 |
4.982600E-01 |
| Stage1-vs-Stage4 |
4.585800E-01 |
| Stage2-vs-Stage3 |
7.716000E-01 |
| Stage2-vs-Stage4 |
5.911200E-01 |
| Stage3-vs-Stage4 |
7.729400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.20560000000025E-06 |
| Normal-vs-AfricanAmerican |
3.64449999999961E-05 |
| Normal-vs-Asian |
6.026100E-04 |
| Caucasian-vs-AfricanAmerican |
8.497600E-01 |
| Caucasian-vs-Asian |
3.642800E-01 |
| AfricanAmerican-vs-Asian |
2.587000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.0788999999819E-07 |
| Normal-vs-Female |
1.575170E-03 |
| Male-vs-Female |
1.118780E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.66210000000545E-05 |
| Normal-vs-Extreme_Weight |
8.38380000000027E-05 |
| Normal-vs-Obese |
3.82810000000289E-05 |
| Normal-vs-Extreme_Obese |
2.047600E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.903800E-01 |
| Normal_Weight-vs-Obese |
9.958200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.755400E-01 |
| Extreme_Weight-vs-Obese |
6.777800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.865200E-01 |
| Obese-vs-Extreme_Obese |
7.152000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.491400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.70159999999653E-05 |
| Normal-vs-Age(61-80Yrs) |
3.24299999998612E-06 |
| Normal-vs-Age(81-100Yrs) |
3.12700000004718E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.592200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.002040E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.938500E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.544600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.020390E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.103400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.64770000005343E-06 |
| Normal-VS-Type2 PRCC |
7.98560000000448E-05 |
| Normal-VS-KIRP CIMP |
3.576400E-01 |
| Normal-VS-Unclassified PRCC |
1.71670999999929E-05 |
| Type1 PRCC-VS-Type2 PRCC |
8.330000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.682010E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.046800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.852830E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.045800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.703700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.76030000001537E-06 |
| Normal-vs-N1 |
2.252400E-02 |
| Normal-vs-N2 |
5.282800E-01 |
| N0-vs-N1 |
7.903900E-02 |
| N0-vs-N2 |
1.810630E-01 |
| N1-vs-N2 |
6.385800E-01 |
|
|
